Back to KROS

D. E. Shaw & Co., Inc. → KROS

D. E. Shaw & Co., Inc. KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
15
Latest value
$254K
Q3 2026
Peak value
$21.1M
First seen
Q2 2022

Dollar value over time

Show data table
PeriodPosition value
Q2 2022$582K
Q1 2024$1.2M
Q2 2024$8M
Q3 2024$10.8M
Q4 2024$192K
Q1 2025$12.9M
Q2 2025$17.3M
Q3 2025$21.1M
Q4 2025$15.4M
Q1 2026$310K
Q1 2026$5.3M
Q2 2026$387K
Q2 2026$2.5M
Q3 2026$1.8M
Q3 2026$254K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$254K22.3K——
Q3 2026$1.8M160.9K——
Q2 2026$2.5M231.3K——
Q2 2026$387K36.1K——
Q1 2026$5.3M481.6K——
Q1 2026$310K28.1K——
Q4 2025$15.4M755.5K——
Q3 2025$21.1M1.33M——
Q2 2025$17.3M1.30M——
Q1 2025$12.9M1.26M——
Q4 2024$192K12.1K——
Q3 2024$10.8M186.3K——
Q2 2024$8M175.7K——
Q1 2024$1.2M18.9K——
Q2 2022$582K21.1K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other D. E. Shaw & Co., Inc. positions

SPY

STATE STR SPDR S&P 500 ETF T

$7.6B
SPY

STATE STR SPDR S&P 500 ETF T

$6.8B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.3B
NVDA

NVIDIA CORPORATION

$2.3B
NVDA

NVIDIA CORPORATION

$2.3B
SPY

SPDR S&P 500 ETF TR

$2B
NVDA

NVIDIA CORPORATION

$2B